Willingness to Travel for Cellular Therapy: The Influence of Follow-Up Care Location, Oncologist Continuity, and Race.

Zachary A K Frosch Esin C NamogluNandita MitraDaniel J Landsburg Sunita D Nasta Justin E BekelmanRaghuram IyengarCarmen E GuerraMarilyn M Schapira

Published in: JCO oncology practice (2021)

Reducing travel burden through shared follow-up may increase patients' willingness to travel to receive cellular therapies, but additional measures are required to facilitate equitable access.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
healthcare
chronic kidney disease
palliative care
peritoneal dialysis
stem cells
infectious diseases
quality improvement
mesenchymal stem cells
pain management
patient reported
smoking cessation